Shoulder Innovations reports Q4 revenue $14.4M (+65%), FY2025 revenue $47.3M (+50%), guides 2026 to $62-65M

SHOULDER INNOVATIONS, INC.

Net revenue Q4 $14.4M (+65% YoY); FY2025 $47.3M (+50% YoY). Gross margin 76.7% Q4, 76.5% FY.
Net loss Q4 $7.8M, FY $40.4M; Adjusted EBITDA loss Q4 $7.0M, FY $36.1M.
Sold 1,976 implant systems in Q4 (+62%); ended 2025 with 134 core/contender surgeons (+61%).
FY2026 revenue guidance $62-65M (31-37% growth); cash $124.3M at Dec 31, 2025.
Director Michael Carusi not standing for re-election; Drew Hykes appointed to Board.

item 2.02 item 5.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SHOULDER INNOVATIONS, INC. updated its fourth quarter and year ended December 31, 2025 guidance (initiated).

Period: fourth quarter and year ended December 31, 2025
Guidance: initiated
Result: reported results

Exact text from the filing

On March 10, 2026, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing financial results for the fourth quarter and year ended December 31, 2025.

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

SHOULDER INNOVATIONS, INC. filing history →

Source: SEC EDGAR

accession 0001699350-26-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.